JP2024527441A5 - - Google Patents

Info

Publication number
JP2024527441A5
JP2024527441A5 JP2024527874A JP2024527874A JP2024527441A5 JP 2024527441 A5 JP2024527441 A5 JP 2024527441A5 JP 2024527874 A JP2024527874 A JP 2024527874A JP 2024527874 A JP2024527874 A JP 2024527874A JP 2024527441 A5 JP2024527441 A5 JP 2024527441A5
Authority
JP
Japan
Prior art keywords
pharmaceutical composition
composition according
doped silicon
particles
pharmaceutical
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2024527874A
Other languages
English (en)
Japanese (ja)
Other versions
JP2024527441A (ja
Filing date
Publication date
Priority claimed from GBGB2110644.8A external-priority patent/GB202110644D0/en
Application filed filed Critical
Publication of JP2024527441A publication Critical patent/JP2024527441A/ja
Publication of JP2024527441A5 publication Critical patent/JP2024527441A5/ja
Pending legal-status Critical Current

Links

JP2024527874A 2021-07-23 2022-07-22 ドープシリコン粒子を含む組成物、及び関連する方法 Pending JP2024527441A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GBGB2110644.8A GB202110644D0 (en) 2021-07-23 2021-07-23 Improved nucleic acid vector particles
GB2110644.8 2021-07-23
PCT/GB2022/051937 WO2023002222A1 (en) 2021-07-23 2022-07-22 Compositions comprising doped silicon particles, and related methods

Publications (2)

Publication Number Publication Date
JP2024527441A JP2024527441A (ja) 2024-07-24
JP2024527441A5 true JP2024527441A5 (https=) 2025-07-29

Family

ID=77541197

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2024527874A Pending JP2024527441A (ja) 2021-07-23 2022-07-22 ドープシリコン粒子を含む組成物、及び関連する方法

Country Status (7)

Country Link
US (1) US20240327841A1 (https=)
EP (1) EP4351510A1 (https=)
JP (1) JP2024527441A (https=)
CN (1) CN117715612A (https=)
AU (1) AU2022315872A1 (https=)
GB (1) GB202110644D0 (https=)
WO (1) WO2023002222A1 (https=)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB202300914D0 (en) 2023-01-20 2023-03-08 Sisaf Ltd Manufacturing process
GB202300915D0 (en) * 2023-01-20 2023-03-08 Sisaf Ltd mRNA COMPOSITIONS
GB202300912D0 (en) * 2023-01-20 2023-03-08 Sisaf Ltd Therapeutic compostions and methods

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5264618A (en) 1990-04-19 1993-11-23 Vical, Inc. Cationic lipids for intracellular delivery of biologically active molecules
WO2009046220A2 (en) * 2007-10-02 2009-04-09 Mdrna, Inc. Lipopeptides for delivery of nucleic acids
IT1394656B1 (it) 2009-07-03 2012-07-05 Brev Angela Srl Processo per la produzione e l'assemblaggio di una siringa per operazioni medicali
GB0913255D0 (en) * 2009-07-30 2009-09-02 Sisaf Ltd Topical composition
NZ606591A (en) * 2010-07-06 2015-02-27 Novartis Ag Cationic oil-in-water emulsions
WO2017181115A1 (en) * 2016-04-14 2017-10-19 Spinnaker Biosciences, Inc. Porous silicon materials comprising a metal silicate for delivery of therapeutic agents
GB201904337D0 (en) * 2019-03-28 2019-05-15 Sisaf Ltd A delivery system
CN112494424A (zh) * 2020-12-04 2021-03-16 合肥澄实生物科技有限公司 一种脂质纳米颗粒制剂及其应用

Similar Documents

Publication Publication Date Title
JP2024527441A5 (https=)
Liu et al. Tetrahedral framework nucleic acids deliver antimicrobial peptides with improved effects and less susceptibility to bacterial degradation
Zhu et al. RNA-based therapeutics: an overview and prospectus
Wang et al. Chiral polypeptide thermogels induce controlled inflammatory response as potential immunoadjuvants
Malik et al. Trimethyl chitosan nanoparticles encapsulated protective antigen protects the mice against anthrax
Liu et al. Hyaluronic acid-modified cationic lipid–PLGA hybrid nanoparticles as a nanovaccine induce robust humoral and cellular immune responses
Scholz et al. Therapeutic plasmid DNA versus siRNA delivery: common and different tasks for synthetic carriers
Rattanakiat et al. The assembly of a short linear natural cytosine-phosphate-guanine DNA into dendritic structures and its effect on immunostimulatory activity
Maloney et al. Nitric oxide-releasing hyaluronic acid as an antibacterial agent for wound therapy
Campos et al. Advancing nanotechnology: Targeting biofilm-forming bacteria with antimicrobial peptides
Tieu et al. Maximizing RNA loading for gene silencing using porous silicon nanoparticles
Huang et al. Synergistic immunostimulation through the dual activation of toll-like receptor 3/9 with spherical nucleic acids
Jiang et al. Complexation of DNA with cationic copolymer micelles: Effects of DNA length and topology
Tam et al. Therapeutic potentials of short interfering RNAs
Yuan et al. Polymer-based nanocarriers for therapeutic nucleic acids delivery
Zou et al. Acid-responsive immune-enhancing chitosan formulation capable of transforming from particle stabilization to polymer chain stabilization
Andrianov et al. Microneedles with intrinsic immunoadjuvant properties: microfabrication, protein stability, and modulated release
JP2022169627A (ja) 腋臭を治療する方法
Movassaghian et al. Efficient down-regulation of PKC-α gene expression in A549 lung cancer cells mediated by antisense oligodeoxynucleotides in dendrosomes
Ros et al. Charge-shifting polycations based on N, N-(dimethylamino) ethyl acrylate for improving cytocompatibility during DNA delivery
Cho Design and development of degradable polyethylenimines for delivery of DNA and small interfering RNA: An updated review
Pereira et al. Advanced biopolymeric materials and nanosystems for RNA/DNA vaccines: a review
CN104523595B (zh) 一种阳离子磷脂-聚合物纳米颗粒及其制备方法
JP2008531672A5 (https=)
JP2008056611A (ja) 医薬製剤